Rapport Therapeutics, Inc. Common StockRAPPNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-124.08M
↓ 101% vs avg
Percentile
P0
Near historical low
Streak
3 yr
Consecutive declineContracting
Average
$-61.64M
Historical baseline
PeriodValueYoY Change
2025$-124.08M-60.2%
2024$-77.47M-123.5%
2023$-34.66M-234.9%
2022$-10.35M-